MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from
divestiture, net of cash...
$96,615K
Net cash provided by
investing activities
$35,419K
Effect of exchange rate
change on cash and cash...
$1,077K
Canceled cashflow
$61,196K
Net decrease in cash
and cash...
-$54,306K
Canceled cashflow
$36,496K
Net income (loss)
$183,452K
Prepaid expenses and
other current assets
-$54,102K
Accrued interest
expense related to sale...
$7,990K
Loss on debt
extinguishments
-$6,583K
Stock-based compensation
$6,576K
Inventories
-$5,362K
Dividend received from
unconsolidated variable...
$3,947K
Impairment of property and
equipment
$2,062K
Operating lease
right-of-use assets
-$808K
Depreciation
$713K
Other long-term
liabilities
$495K
Amortization of finance lease
right-of-use assets
$35K
Accrued interest for
finance lease...
$6K
Purchases of
available-for-sale securities
$61,158K
Purchases of property and
equipment
$38K
Net cash used in
financing activities
-$86,028K
Net cash used in
operating activities
-$4,774K
Canceled cashflow
$272,131K
Repayments of senior
secured term loan...
$75,000K
Payment of senior
secured term loan...
$5,550K
Cash paid to
non-controlling interest
$5,353K
Cash paid for payroll
taxes on restricted...
$69K
Payment of issuance cost
under atm program
$46K
Repayments of finance lease
liabilities
$10K
Deferred revenues
-$136,429K
Accrued and other
liabilities
-$53,497K
Gain on divestiture
$52,553K
Accounts payable
-$27,654K
Accounts receivable, net
$2,543K
Investment income in
unconsolidated variable...
$2,485K
Other assets
$902K
Operating lease
liabilities, current
-$568K
Operating lease
liabilities, non-current
-$202K
Net accretion of
premium and discount on...
$72K
Back
Back
Cash Flow
source: myfinsight.com
KYNTRA BIO, INC. (KYNB)
KYNTRA BIO, INC. (KYNB)